Skip to main content

Peer Review reports

From: Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways

Original Submission
20 Aug 2016 Submitted Original manuscript
1 Sep 2016 Author responded Author comments - Masatoshi Tagawa
Resubmission - Version 2
1 Sep 2016 Submitted Manuscript version 2
21 Nov 2016 Reviewed Reviewer Report - Carlos J. Ciudad
9 Feb 2017 Reviewed Reviewer Report - Frances Lennon
11 Mar 2017 Author responded Author comments - Masatoshi Tagawa
Resubmission - Version 3
11 Mar 2017 Submitted Manuscript version 3
12 Apr 2017 Author responded Author comments - Kengo Shimazu
Resubmission - Version 4
12 Apr 2017 Submitted Manuscript version 4
18 Apr 2017 Author responded Author comments - Kengo Shimazu
Resubmission - Version 5
18 Apr 2017 Submitted Manuscript version 5
Publishing
25 Apr 2017 Editorially accepted
2 May 2017 Article published 10.1186/s12885-017-3300-y

You can find further information about peer review here.

Back to article page